From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

SourceBio International – proposed AIM cancellation and tender offer, why might there have been a lack of investor “attention”?

By Steve Moore | Wednesday 23 November 2022

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

SourceBio International (SBI) has announced proposed cancellation of its, AIM, stock market listing and a “tender offer pursuant to which up to 11,071,810 ordinary shares (representing approximately 14.9 per cent. of the existing share capital of the company) would be purchased by the company at a price of 115 pence per ordinary share”. With the shares currently 110p and there 74,183,038 in issue, why is this proposed and what does it mean for shareholders?

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



Anpario – a recovery Buy?...

Thursday »


Bearcast issue update: all should be well



Oracle Power: Cynical Foul

Time left: 09:02:13